A vancomycin drug use evaluation and economic analysis in a cancer treatment centre.
Princess Margaret Hospital is a 140-bed university affiliated cancer treatment centre. Vancomycin was the only formulary agent available for the treatment of methicillin-resistant gram-positive organisms. The high cost and potential toxicity of this drug warranted a closer examination of its use. The purpose of this study was to evaluate vancomycin use and to determine the economic impact when it was used contrary to newly developed hospital guidelines. A sample of 100 vancomycin orders was randomly selected from all prescriptions filled in 1992. The indication, dose, and duration of therapy for each order were compared against the hospital guidelines. The cost savings associated with altering the sample of prescriptions to meet hospital guidelines were then determined. Nine percent of the prescriptions were for nonapproved indications. The actual dose used did not meet criteria in 32% of cases and the length of therapy was beyond the approved duration in 45% of the orders. If the cases had been altered to meet the guidelines then a total savings of $13,581 would have been realized. The projected savings for the entire year (1992) would have been $100,907. The critical problem areas in vancomycin prescribing were the duration of therapy and dose. The results have provided the impetus to initiate a hospital wide prospective Drug Utilization Evaluation (DUE) study to optimize vancomycin prescribing. The program costs would be easily covered by the expected savings.
Ontario Cancer Institute/Princess Margaret Hospital, Toronto.
G
G
Dranitsaris
N J
NJ
Pilla
A
A
McGreer
D002173:Cancer Care Facilities / Q000191:economics*; D003365:Costs and Cost Analysis; D016527:Drug Costs / Q000706:statistics & numerical data*; D017723:Drug Utilization Review / Q000191:economics* / Q000706:statistics & numerical data; D006744:Hospital Bed Capacity, 100 to 299; D006784:Hospitals, Teaching / Q000191:economics; D006801:Humans; D009503:Neutropenia / Q000188:drug therapy; D009864:Ontario; D010607:Pharmacy Service, Hospital / Q000191:economics*; D017410:Practice Guidelines as Topic; D011795:Surveys and Questionnaires; D014640:Vancomycin / Q000008:administration & dosage* / Q000191:economics / Q000633:toxicity